Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Power-Hays

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Journal of Pediatric Gastroenterology and Nutrition|October 25, 2021
Clinical Characteristics and Short-Term Outcomes of Children With Asparaginase-Associated PancreatitisErin E Mauney, Alexandra Power-Hays, Yael Flamand, et al.
Pediatric Blood & Cancer|February 23, 2017
Delivery of radiation therapy in resource-limited settings: A pilot quality assessment studyAlexandra Power-Hays, Paola Friedrich, Gretchen Fernandez, et al.
Clinical Pharmacology and Therapeutics|November 29, 2023
Rationale, Development, and Validation of HdxSim, a Clinical Decision Support Tool for Model-Informed Precision Dosing of Hydroxyurea for Children with Sickle Cell AnemiaAlexandra Power-Hays, Min Dong, Nieko Punt, et al.
Pediatric Blood & Cancer|April 20, 2022
US News & World Report and quality metrics: Inclusion of sickle cell disease is a matter of equityAlexandra Power-Hays, Christopher E Dandoy, Angela Lorts, et al.
Clinical Dysmorphology|November 2, 2020
Delayed diagnosis of Williams-Beuren syndrome in an adolescent of Jamaican descent: examining racial disparities in genetics educationNina B Gold, Katherine A Nash, Joanna Perdomo, et al.
Frontiers in Molecular Biosciences|June 16, 2023
Hydroxyurea pharmacokinetics and precision dosing in low-resource settingsLuke R Smart, Mwesige Charles, Kathryn E McElhinney, et al.
Blood Advances|December 3, 2025
Increasing ketamine administration in children's hospitals for youth with sickle cell diseaseAshley Jenkins, Erin Hendry, Alexandra Power-Hays, et al.
American Journal of Hematology|February 9, 2024
Reducing transfusion utilization for children with sickle cell anemia in sub-Saharan Africa with hydroxyurea: Analysis from the phase I/II REACH trialAlexandra Power-Hays, George A Tomlinson, Leon Tshilolo, et al.
British Journal of Clinical Pharmacology|April 13, 2025
The feasibility of pharmacokinetic-based dosing of hydroxyurea for children with sickle cell anaemia in Uganda: Baseline results of the alternative dosing and prevention of transfusions trialAlexandra Power-Hays, Ruth Namazzi, Min Dong, et al.
Acta Haematologica|June 2, 2024
Pharmacokinetic-Guided Hydroxyurea to Reduce Transfusions in Ugandan Children with Sickle Cell Anemia: Study Design of the Alternative Dosing And Prevention of Transfusions TrialAlexandra Power-Hays, Ruth Namazzi, Charles Kato, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Pediatric Gastroenterology and Nutrition|October 25, 2021
Clinical Characteristics and Short-Term Outcomes of Children With Asparaginase-Associated PancreatitisErin E Mauney, Alexandra Power-Hays, Yael Flamand, et al.
Pediatric Blood & Cancer|February 23, 2017
Delivery of radiation therapy in resource-limited settings: A pilot quality assessment studyAlexandra Power-Hays, Paola Friedrich, Gretchen Fernandez, et al.
Clinical Pharmacology and Therapeutics|November 29, 2023
Rationale, Development, and Validation of HdxSim, a Clinical Decision Support Tool for Model-Informed Precision Dosing of Hydroxyurea for Children with Sickle Cell AnemiaAlexandra Power-Hays, Min Dong, Nieko Punt, et al.
Pediatric Blood & Cancer|April 20, 2022
US News & World Report and quality metrics: Inclusion of sickle cell disease is a matter of equityAlexandra Power-Hays, Christopher E Dandoy, Angela Lorts, et al.
Clinical Dysmorphology|November 2, 2020
Delayed diagnosis of Williams-Beuren syndrome in an adolescent of Jamaican descent: examining racial disparities in genetics educationNina B Gold, Katherine A Nash, Joanna Perdomo, et al.
Frontiers in Molecular Biosciences|June 16, 2023
Hydroxyurea pharmacokinetics and precision dosing in low-resource settingsLuke R Smart, Mwesige Charles, Kathryn E McElhinney, et al.
Blood Advances|December 3, 2025
Increasing ketamine administration in children's hospitals for youth with sickle cell diseaseAshley Jenkins, Erin Hendry, Alexandra Power-Hays, et al.
American Journal of Hematology|February 9, 2024
Reducing transfusion utilization for children with sickle cell anemia in sub-Saharan Africa with hydroxyurea: Analysis from the phase I/II REACH trialAlexandra Power-Hays, George A Tomlinson, Leon Tshilolo, et al.
British Journal of Clinical Pharmacology|April 13, 2025
The feasibility of pharmacokinetic-based dosing of hydroxyurea for children with sickle cell anaemia in Uganda: Baseline results of the alternative dosing and prevention of transfusions trialAlexandra Power-Hays, Ruth Namazzi, Min Dong, et al.
Acta Haematologica|June 2, 2024
Pharmacokinetic-Guided Hydroxyurea to Reduce Transfusions in Ugandan Children with Sickle Cell Anemia: Study Design of the Alternative Dosing And Prevention of Transfusions TrialAlexandra Power-Hays, Ruth Namazzi, Charles Kato, et al.
Pageof 3